Natera CEO Steven Chapman offloaded 1,698 shares via a pre-established 10b5-1 trading plan, a move that market observers view as routine given the stock's 91% return over the past year.
CEO Steven Chapman sold 1,698 shares under a prearranged Rule 10b5-1 plan, representing a minimal ownership stake reduction and no indication of negative company news.
Natera CEO Steven Chapman sold 1,698 shares of common stock on September 1, 2026, in a transaction valued at approximately $545,000. The sale was executed under a prearranged Rule 10b5-1 trading plan, signaling a routine divestment rather than a shift in company outlook. Chapman retains a direct stake of 98,199 shares in the molecular diagnostics firm.
No. The transaction was part of a prearranged Rule 10b5-1 plan, which is designed to allow insiders to sell shares without triggering concerns regarding material non-public information.